Trial intelligence / Profile preview

Phase 2 Single-Arm Study of Lazertinib in NSCLC with EGFR T790M Mutation Detected by BALiquid

KCT0006841Phase 2Completed

Sponsor

Yuhan

Start

Apr 2022

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1